SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Richard A. Hoker, Vice President and Corporate Controller and Chief Accounting Officer, has informed CF Industries that he intends to retire effective March 3, 2027. This is a clear departure of a named executive officer responsible for accounting and financial controls, which is material to investors' assessment of the company's financial reporting and governance.
View raw filing on EDGAR →NextCure entered into a Ninth Amendment to its lease agreement that accelerates termination of its laboratory and office space at 8000 Virginia Manor Road, Beltsville, Maryland, effective September 1, 2026, with a one-time termination fee of approximately $0.8 million and forfeiture of a $39,000 security deposit. This is a material operational event involving the early exit from a significant facility lease (approximately 29,864 rentable square feet), though it does not fit the specific categories of M&A activity, workforce reduction, or other named operational types. The materiality is supported by the substantial termination costs and the apparent strategic decision to vacate the premises.
View raw filing on EDGAR →The filing discloses the appointment of three new directors (Richard Shorten, Todd Larsen, and Lok Lee) effective September 3, 2026, to fill vacancies created by three resignations. While both departures and appointments occur, the principal disclosed action centers on the Board's appointment of the new directors and their committee assignments. The appointment of Richard Shorten is particularly material given his significant related-party transactions: he controls Silvermine Capital Advisors (40% owner of GlobalStake), which serves as investment adviser to Comstock MultiChain Fund—a current shareholder that participated in prior PIPEs and has ongoing financial relationships with the Company totaling millions in proceeds and warrant exercises.
View raw filing on EDGAR →Polestar entered into a USD 400 million term loan facility with GSAI on September 3, 2026, consisting of a USD 100 million committed Term A Loan and a USD 300 million uncommitted Term B Loan (disbursable in RMB). This is a material creation of direct financial obligations with specified interest rates, covenants, and events of default, fitting the debt_issuance category. The facility includes an equity conversion option, but the primary disclosed action is the establishment of the debt facility itself.
View raw filing on EDGAR →This is an earnings release disclosing interim financial results for Q2 2026 (three months ended June 30, 2026). The exhibit presents total revenues of $96.8 million, operating income of $15.6 million, net income of $3.4 million, and Adjusted EBITDA of $57.6 million, along with detailed financial analysis and operational highlights. The document is explicitly titled "EARNINGS RELEASE—INTERIM RESULTS FOR THE PERIOD ENDED JUNE 30, 2026" and includes comparative analysis to prior quarters and year-over-year results, which is characteristic of a quarterly earnings disclosure.
View raw filing on EDGAR →Justin Nolan ceased to serve as Chief Executive Officer and Executive Director effective August 30, 2026. The press release explicitly announces his departure and details a separation agreement with a $250,000 cash payment. The departure of a CEO is material to investors as it affects leadership continuity and operational oversight, particularly given the Company's stated focus on AI infrastructure and data center opportunities.
View raw filing on EDGAR →Net Power Inc. closed the acquisition of EMPower USA's contractual rights and obligations under an EPC agreement for a 123 MW natural gas power generation facility on August 31, 2026. The transaction involved $58.9 million in cash consideration plus assumption of approximately $177.8 million in future payment commitments, representing a material acquisition of contractual rights and project assets that advances the company's Project Permian development strategy. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and constitutes a material acquisition activity.
View raw filing on EDGAR →Charles & Colvard, Ltd. filed a voluntary Chapter 11 petition on March 2, 2026, in the U.S. Bankruptcy Court for the Eastern District of North Carolina (Case No. 26-00969-5-DMW). The Item 7.01 disclosure reports the company's monthly operating report for July 2026, which confirms the company "sold its assets during the reporting period and ceased operations" and is "working with counsel to formulate its Chapter 11 Plan." This is a terminal event—bankruptcy filing—that materially threatens the registrant's continued existence.
View raw filing on EDGAR →Rainier Acquisition Corp consummated a private placement of 5,625 Private Placement Units at $10.00 per unit on September 2, 2026, pursuant to Section 4(a)(2) exemption from registration. The units consist of Class A ordinary shares and warrants, issued to Sponsor Ravenna 7 LLC.
View raw filing on EDGAR →Rainier Acquisition Corp completed its IPO on August 26, 2026, generating $86.25 million in gross proceeds (including over-allotment), with $75 million placed in a trust account. The disclosure documents the company's capitalization structure, unit composition, and warrant terms.
View raw filing on EDGAR →The disclosure announces the board's resolution on 2 September 2026 to accelerate vesting of 2,159,127 unvested share options and 60,974 unvested RSUs held by departing CEO Mikael Skov, resulting in vested rights to 2,220,101 shares. This is a material modification to executive compensation arrangements triggered by his departure, falling squarely within exec_compensation (equity grants and compensation plan amendments). While Skov's departure was previously announced on 30 June 2026, this exhibit focuses on the compensatory consequence—the accelerated vesting decision—rather than the departure itself.
View raw filing on EDGAR →Apogee Therapeutics completed its merger with AbbVie, becoming an indirect wholly owned subsidiary of AbbVie in a transaction valued at approximately $10.9 billion. The merger resulted in a change of control, conversion of Apogee shares into merger consideration, delisting from Nasdaq, and replacement of all directors and executive officers with AbbVie-designated personnel.
View raw filing on EDGAR →Campbell Fund Trust sold unregistered Units of Beneficial Interest totaling approximately $5.2 million across three series (A, D, W) on August 31, 2026, in reliance on Section 4(2) of the Securities Act and Regulation D. This is a classic private placement of equity securities by a fund trust to existing and new unitholders, which materially dilutes existing interests and raises capital through an unregistered offering.
View raw filing on EDGAR →Bank7 Corp. has been designated the successful bidder in a court-supervised auction to acquire approximately 71% of Century Financial Services Corporation for $91 million (net $89 million). This represents a material acquisition of a controlling interest in a bank holding company with $1.36 billion in assets, creating a combined organization with approximately $3.4 billion in assets. The transaction is a significant M&A activity subject to regulatory approvals and expected to close in Q4 2026.
View raw filing on EDGAR →Heidi O'Neill resigned from Spotify's Board of Directors effective September 3, 2026. The disclosure explicitly states her departure and includes a quote from CEO Daniel Ek acknowledging her nearly nine-year tenure and contributions to the company's strategy. Board departures are material governance events affecting investor assessment of leadership continuity.
View raw filing on EDGAR →Ragnar Udd has been appointed President and Chief Executive Officer of Albemarle effective February 1, 2027, and will join the Board of Directors. The appointment follows a comprehensive Board succession planning process and includes detailed compensatory arrangements (base salary $1.3M, sign-on bonus $1.4M, make-whole equity awards of $11M, and 2027 LTI awards of $7.5M). J. Kent Masters transitions from CEO to Executive Chairman as part of a well-defined succession plan.
View raw filing on EDGAR →This press release announces completion of the last patient visit in the NATiV3 Phase 3 clinical trial of lanifibranor for MASH treatment, with topline results expected in Q4 2026. This is a material clinical development milestone for a clinical-stage biopharmaceutical company whose lead product candidate is in pivotal Phase 3 testing. The event is operational/strategic (a key trial milestone) rather than a discrete financial, governance, or legal event, and does not fit the specific categories of earnings release, M&A, or other named types. The company has received FDA Breakthrough Therapy and Fast Track designations, and successful trial results could support regulatory submission and commercialization in 2027–2028, making this milestone material to investors assessing the company's pipeline progress and value.
View raw filing on EDGAR →Shell plc announces completion of its acquisition of ARC Resources Ltd., a material M&A transaction. The filing states "Shell plc has completed the previously announced agreement...to acquire ARC Resources Ltd." with an enterprise value of approximately US$16.5 billion, funded via US$3.3 billion in cash and US$10.6 billion in new Shell shares. The transaction adds approximately 370 kboe/d of production and is expected to generate double-digit returns and be accretive to free cash flow from 2027 onwards—clearly material to a reasonable investor's assessment of Shell's strategic direction and financial position.
View raw filing on EDGAR →Richard R. Fabian was appointed President of Profound Medical effective September 1, 2026, succeeding Mathieu Burtnyk who transitioned to Chief Technology Officer. Fabian brings 29+ years of healthcare industry experience, including prior roles as CEO of FUJIFILM Sonosite and executive positions at Philips Healthcare and STERIS, with a compensation package of $550,000 base salary, up to 100% bonus, 200,000 RSUs, and 475,000 options.
View raw filing on EDGAR →The filing discloses a 1-for-50 reverse share split approved by the Board on August 17, 2026, explicitly stated to be "intended to increase the market price per share of the Company's ordinary shares to allow the Company to maintain compliance with Nasdaq continued listing requirements." This is a material disclosure of delisting risk — the company is taking corrective action to avoid falling below Nasdaq's minimum bid price requirement, a clear signal of listing compliance jeopardy.
View raw filing on EDGAR →The press release announces that Hooker Furnishings' board of directors declared a quarterly cash dividend of $0.115 per share, payable on September 30, 2026, to shareholders of record on September 15, 2026. This is a straightforward dividend declaration, which is a material capital allocation event affecting shareholders.
View raw filing on EDGAR →Alpha Compute Corp announced a 1-for-50 reverse share split effective September 9, 2026, explicitly stating the split is "intended to increase the market price per share of the Company's ordinary shares to allow the Company to maintain compliance with Nasdaq continued listing requirements." This disclosure reveals the company faces delisting risk due to failure to satisfy Nasdaq's minimum bid price requirement, making this a material delisting-risk event.
View raw filing on EDGAR →This is a clear earnings release for Q3 2026 (three months ended July 31, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including net sales of $501.8 million, net income of $26.5 million, diluted EPS of $0.58, and adjusted EBITDA of $72.7 million, along with segment performance, balance sheet metrics, and cash flow data. The filing explicitly states "On September 3, 2026, the Registrant issued a press release" and the exhibit contains the full quarterly earnings announcement with detailed financial tables and management commentary.
View raw filing on EDGAR →The Korean Government announced a "Plan for Functional Reform of Public Institutions" proposing to merge five power generation subsidiaries of Korea Electric Power Corporation into a single entity. This constitutes a material change of control or restructuring of the registrant's operating subsidiaries. While the disclosure is preliminary and unconfirmed, the announcement of a government-mandated merger proposal affecting core operating assets qualifies as ma_activity under Items 1.01 or 2.01 (material acquisition or change of control), even though the transaction is not yet finalized.
View raw filing on EDGAR →This is a press release disclosing BRP's second quarter fiscal 2027 financial results, including revenues of $2,236.8 million (up 18.5%), net loss of $136.8 million, and normalized EBITDA of $138.8 million. The release also includes revised full-year FY27 guidance and highlights material operational developments (product launches, market share gains, financial leadership transition). This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →The Item 7.01 disclosure announces completion of a merger between Hornbeck Offshore Services and Helix, with the combined company creating a "premier integrated offshore services leader in deepwater." The presentation explicitly states "Merger completed September 1, 2026" and describes the pro forma combined entity with 85 vessels, $2.0bn total backlog, and $551mm LTM Adjusted EBITDA. This is a material acquisition/change of control event that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →This is a press release announcing Hello Group Inc.'s unaudited financial results for the second quarter of 2026, including net revenues (RMB2,486.0 million), net income attributable to shareholders (RMB237.4 million), and diluted EPS (RMB1.52 per ADS). The document explicitly states "Hello Group Inc. Announces Unaudited Financial Results for the Second Quarter of 2026" and provides detailed quarterly and first-half financial performance metrics, making it a classic earnings release disclosure material to investors.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 fiscal 2026 ended July 31, 2026. The Item 2.02 disclosure announces financial results including net revenue of $302.0 million (up 2.7% YoY), net income of $3.5 million ($0.11 EPS), and provides forward guidance for Q3 and full fiscal 2026. The press release is furnished as Exhibit 99.1 and includes detailed financial highlights, balance sheet data, and management commentary—all hallmarks of an earnings_release classification.
View raw filing on EDGAR →The exhibit announces a board-approved share repurchase program authorizing the Company to repurchase up to US$10 million of its ordinary shares over a 12-month period starting September 3, 2026. Share repurchase programs are classified as dividend_distribution events under the taxonomy, as they represent a return of capital to shareholders. The $10 million authorization is material to a reasonable investor assessing capital allocation and shareholder value.
View raw filing on EDGAR →Genesco Inc. issued a press release on September 3, 2026, announcing second quarter fiscal 2027 results for the period ended August 1, 2026. The disclosure includes net sales of $530 million, comparable sales metrics by segment, gross margin and operating income analysis, GAAP and adjusted EPS figures, and updated full-year guidance raising adjusted EPS to the high end of the $2.00 to $2.40 range. This is a standard quarterly earnings release with financial results and forward guidance, clearly falling under Item 2.02 and the earnings_release event type.
View raw filing on EDGAR →Duluth Holdings disclosed financial results for fiscal Q2 2026 ended August 2, 2026, reporting net income of $18.4 million (vs. $1.3 million prior year) and adjusted EBITDA of $27.0 million (vs. $12.0 million prior year), while raising full-year adjusted EBITDA guidance to $38–$42 million.
View raw filing on EDGAR →Equity Bancshares entered into a definitive Agreement and Plan of Reorganization with Lincoln Bancorp on September 2, 2026, whereby Merger Sub will merge with and into Lincoln, with Lincoln surviving as a wholly owned subsidiary of Equity. The transaction is valued at approximately $123.8 million, adds 16 locations and $1.7 billion in assets, and is expected to close in Q4 2026 subject to regulatory and shareholder approvals.
View raw filing on EDGAR →Climb Bio disclosed positive Phase 1 trial results for CLYM116, an anti-APRIL monoclonal antibody, including a ~29-day half-life, >90% APRIL suppression, and favorable safety profile supporting every-12-week dosing. This is a material clinical development milestone for a lead pipeline asset, but does not constitute an earnings release (no financial results), M&A activity, or other specifically-defined event type. The disclosure is clearly operational—a significant clinical program update—rather than financial, governance, or legal in nature.
View raw filing on EDGAR →Joseph M. Miller has been appointed as Chief Financial Officer of LB Pharmaceuticals effective September 2, 2026. The appointment includes compensatory arrangements comprising a base salary of $530,000, a target bonus of 40%, and an equity option grant of 200,000 shares. Miller brings extensive biopharmaceutical finance experience and will support the company through a potentially transformative period including pivotal clinical trial results and potential commercialization of LB-102.
View raw filing on EDGAR →Aptevo announced positive interim clinical trial results for mipletamig in TP53-mutated AML patients, reporting a 93% clinical benefit rate and 79% CR/CRi rate that compares favorably to published benchmarks. This is a material operational/clinical milestone for a clinical-stage biotech company, as it represents significant progress in a lead program and addresses an unmet medical need in a difficult-to-treat patient population. While not a formal earnings release or regulatory approval, the clinical data disclosure is material to investors' assessment of the company's pipeline value and development trajectory.
View raw filing on EDGAR →This exhibit is a press release announcing StealthGas Inc.'s unaudited financial and operating results for the second quarter and six months ended June 30, 2026. The document discloses net income of $17.3 million (Q2) and $33.2 million (6M), earnings per share of $0.46 (Q2) and $0.89 (6M), revenues of $42.9 million (Q2) and $85.8 million (6M), along with detailed operational metrics and fleet updates. This is a classic earnings release announcing periodic financial results to the market.
View raw filing on EDGAR →CarGurus announced the appointment of Matthew Mandel as Chief Financial Officer, effective October 19, 2026, with a compensation package including a $450,000 base salary, $450,000 target bonus, $250,000 sign-on bonus, and $5.5 million in RSUs. Mandel succeeds Jason Trevisan, who served as interim CFO since March 2025.
View raw filing on EDGAR →Paul H. Brown's resignation from the board of directors of Old Dominion Electric Cooperative, effective September 1, 2026, is a clear departure event. The filing discloses a director leaving the board, which is material to investors' assessment of governance and board composition at the registrant.
View raw filing on EDGAR →On August 28, 2026, Fortress Credit Realty Income Trust entered into a definitive agreement to issue a commercial real estate collateralized loan obligation (CRE CLO) through subsidiary entities, comprising nine classes of notes totaling approximately $900 million in principal amount across secured and unsecured tranches with specified terms, collateral backing, interest rates, and maturity provisions.
View raw filing on EDGAR →The filing discloses a declaration of distributions by HPS Real Assets Lending Company LP to holders of multiple share classes (I, D, S, F-I, F-D, F-S, and E Shares) across Series I and Series II, with specific per-share amounts ranging from $0.0712 to $0.1035. The distributions are payable on or about September 30, 2026, and may be paid in cash or reinvested. This is a routine but material capital return to shareholders that would affect investor assessment of yield and cash flow.
View raw filing on EDGAR →The filing discloses the dismissal of Wolf & Company, P.C. as the independent registered public accounting firm on September 2, 2026, and the concurrent engagement of Deloitte & Touche LLP as the new auditor. This is a classic auditor change under Item 4.01, with explicit confirmation that there were no disagreements or reportable events with the departing auditor, and no prior consultations with the incoming auditor on accounting matters.
View raw filing on EDGAR →Planet Labs issued a press release on September 3, 2026 announcing financial results for its second fiscal quarter ended July 31, 2026, disclosing record quarterly revenue of $116.1 million (58% YoY growth), adjusted EBITDA profit of $13.9 million, and cash position of $865.4 million. The filing explicitly states the press release is attached as Exhibit 99.1 and is incorporated by reference, which is the standard disclosure mechanism for earnings releases under Item 2.02.
View raw filing on EDGAR →BCP Investment Corporation entered into a note purchase agreement on September 2, 2026, to issue $10,000,000 in aggregate principal amount of 7.50% notes due 2029, with proceeds intended to repay existing indebtedness.
View raw filing on EDGAR →This disclosure concerns a material modification to the rights of ADS holders through Amendment No. 1 to the Deposit Agreement, which establishes a mandatory exchange mechanism converting ADSs to ordinary shares upon termination of the ADS program and listing on NYSE. While the event involves a capital structure change, it is fundamentally a governance/shareholder-rights matter—the amendment modifies the contractual rights and economic interests of a class of security holders. This does not fit the specific categories of dilutive issuance, debt issuance, or other financial events, making governance_other the most appropriate classification.
View raw filing on EDGAR →IDEX Corporation amended and restated its credit agreement on September 3, 2026, extending the maturity date of an $800 million revolving credit facility from November 1, 2027 to September 3, 2031. This material amendment extends the term of a major credit facility, affecting the company's capital structure and liquidity profile.
View raw filing on EDGAR →Graphic Packaging entered into a loan agreement with MEDC for $115.2 million in tax-exempt green bonds due 2064, creating a direct financial obligation. The company will use net proceeds of approximately $116.2 million to pay down higher-cost debt. This is a material debt issuance disclosed under Item 2.03, creating a new direct financial obligation for the registrant.
View raw filing on EDGAR →PIMCO Asset-Based Lending Company LLC issued and sold approximately $31.2 million in unregistered limited liability company interests (equity securities) across multiple share classes to third-party investors on August 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →The company declared distributions on August 31, 2026, across eight share classes with per-share amounts ranging from $0.0623 to $0.0809, payable on or about September 21, 2026.
View raw filing on EDGAR →T-Mobile appointed Jessica Uhl as Chief Financial Officer Designate effective mid-September 2026, with transition to CFO in February 2027, succeeding Peter Osvaldik. The appointment includes detailed compensation terms: $975,000 base salary, $1M sign-on bonus, and $9.525M in long-term incentive awards.
View raw filing on EDGAR →This is a clear earnings release disclosing Smith & Wesson's first quarter fiscal 2027 financial results. The press release (Exhibit 99.1) reports Q1 net sales of $112.6 million (up 32.3% YoY), gross margin of 28.7%, and EPS of $0.06/share (versus a loss of $0.08 in the prior year). The filing explicitly states it is "furnishing the disclosure in this Item 2.02 in connection with the disclosure of information in the form of the textual information from a press release issued on September 3, 2026," which is the standard Item 2.02 treatment for quarterly earnings announcements.
View raw filing on EDGAR →